Mariana Raquel Antunes Colaço

Team icon

PhD Student

Overview

Mariana Colaço completed in 2016 the Bachelor Degree in Biochemistry (University of Coimbra, Faculty of Science and Technology), and the Master Degree in Pharmaceutical Biotechnology in 2018 with a dissertation entitled "Development of nanosized glucan particles with immunostimulatory function as a delivery system for curcumin" (University of Coimbra, Faculty of Pharmacy). Currently, she is a PhD student in Pharmaceutical Sciences (Pharmaceutical Technology) in Faculty of Pharmacy (University of Coimbra) working on the project: "Designing cationic polymer-DNA complexes for nasal immunization against SARS-CoV-2". Since the completion of her MsD (2018), Mariana Colaço has published 2 articles as first author and 4 articles as co-author. She participated as a Master Student Fellow in 2 projects: an international PROSAFE project (GoNanoBioMat) and a project for the development of a therapeutic vaccine against chronic hepatitis B using glucan based adjuvant nanocarriers. In her professional activities has interacted with 15 collaborators/ co-authorship of scientific papers. In her curriculum Ciência Vitae the most frequent terms in the context of scientific and technological output are: Polymeric; nanoparticles; curcumin; glucan; immunotoxicity; anti-inflammatory; therapeutic; safe-by-design; in vitro; immune response.

Publications

Show less

Information about journal articles, updated at 17-11-2024, from platform CIÊNCIAVITAE.

Exploring the immunomodulatory properties of glucan particles in human primary cells

Jesus, Sandra; Panão Costa, João; Colaço, Mariana; Lebre, Filipa; Mateus, Daniela; Sebastião, Ana Isabel; Cruz, Maria Teresa; Alfaro-Moreno, Ernesto; Borges, Olga, International Journal of Pharmaceutics. 2024. https://doi.org/10.1016/j.ijpharm.2024.123996 . 10.1016/j.ijpharm.2024.123996 . published International Journal of Pharmaceutics

Endotoxin contamination of nanoparticle formulations: A concern in vaccine adjuvant mechanistic studies

Costa, João Panão; Jesus, Sandra; Colaço, M.; Duarte, Alana; Soares, Edna; Borges, Olga, Vaccine. 3481 - 3485. 23. 41. 2023. http://dx.doi.org/10.1016/j.vaccine.2023.04.063 . 10.1016/j.vaccine.2023.04.063 . published Vaccine

The Effect of Curcumin-Loaded Glucan Nanoparticles on Immune Cells: Size as a Critical Quality Attribute

Colaço, M.; Roquito, Tiago; Costa, João Panão; Cruz, Maria Teresa; Borges, Olga, Pharmaceutics. 2. 15. 2023. http://dx.doi.org/10.3390/pharmaceutics15020623 . 10.3390/pharmaceutics15020623 . published Pharmaceutics

Unravelling the Immunotoxicity of Polycaprolactone Nanoparticles—Effects of Polymer Molecular Weight, Hydrolysis, and Blends

Jesus, Sandra; Bernardi, Natalia; da Silva, Jessica; Colaço, Mariana; Panão Costa, João; Fonte, Pedro; Borges, Olga, Chemical Research in Toxicology. 2819 - 2833. 11. 33. 2020. http://dx.doi.org/10.1021/acs.chemrestox.0c00208 . 10.1021/acs.chemrestox.0c00208 . published Chemical Research in Toxicology

Airborne environmental fine particles induce intense inflammatory response regardless of the absence of heavy metal elements

Colaço, Mariana; Duarte, Alana; Zuzarte, Mónica; Costa, Benilde F.O.; Borges, Olga, Ecotoxicology and Environmental Safety. 195. 2020. http://dx.doi.org/10.1016/j.ecoenv.2020.110500 . 10.1016/j.ecoenv.2020.110500 . published Ecotoxicology and Environmental Safety

All projects

Show less

Information of exclusive responsibility of the researcher 17-11-2024 , from platform CIÊNCIAVITAE.

2021/12/01 - 2022/12/01

Vacina Intranasal genética contra o COVID: estudos de imunização em murganhos

13824

Researcher

Universidade de Coimbra Faculdade de Farmácia

Funders: Gilead Sciences Lda

2019/11/20 - 2021

Hepatitis B therapeutic vaccine: Production of glucan-based nanoparticles towards selective delivery hepatitis B antigens to immune cells to induce antiviral activity

PTDC/MEC-GAS/30331/2017

Research Fellow

Funders: Fundação para a Ciência e a Tecnologia

2017/04/01 - 2019/06/30

Polymeric NanoBioMaterials for drug delivery: developing and implementation of safe-by-design concept enabling safe healthcare solutions

ProSafe/0001/2016

Research Fellow

Funders: Fundação para a Ciência e a Tecnologia

We use cookies to improve your visit to our website.